FRESENIUS MEDICAL CARE AG (FME.DE) Fundamental Analysis & Valuation

FRA:FME • DE0005785802

Current stock price

38.95 EUR
-0.65 (-1.64%)
Last:

This FME.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. FME.DE Profitability Analysis

1.1 Basic Checks

  • FME had positive earnings in the past year.
  • In the past year FME had a positive cash flow from operations.
  • FME had positive earnings in each of the past 5 years.
  • FME had a positive operating cash flow in each of the past 5 years.
FME.DE Yearly Net Income VS EBIT VS OCF VS FCFFME.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

1.2 Ratios

  • FME's Return On Assets of 3.16% is fine compared to the rest of the industry. FME outperforms 64.29% of its industry peers.
  • The Return On Equity of FME (7.35%) is comparable to the rest of the industry.
  • FME has a Return On Invested Capital (5.30%) which is comparable to the rest of the industry.
  • The Average Return On Invested Capital over the past 3 years for FME is below the industry average of 6.23%.
  • The last Return On Invested Capital (5.30%) for FME is above the 3 year average (4.02%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.16%
ROE 7.35%
ROIC 5.3%
ROA(3y)2.08%
ROA(5y)2.19%
ROE(3y)4.9%
ROE(5y)5.43%
ROIC(3y)4.02%
ROIC(5y)3.98%
FME.DE Yearly ROA, ROE, ROICFME.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • FME has a better Profit Margin (4.98%) than 71.43% of its industry peers.
  • In the last couple of years the Profit Margin of FME has declined.
  • FME has a Operating Margin of 9.00%. This is in the better half of the industry: FME outperforms 75.00% of its industry peers.
  • FME's Operating Margin has declined in the last couple of years.
  • FME's Gross Margin of 25.62% is fine compared to the rest of the industry. FME outperforms 60.71% of its industry peers.
  • FME's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9%
PM (TTM) 4.98%
GM 25.62%
OM growth 3Y10.69%
OM growth 5Y-6.44%
PM growth 3Y12.82%
PM growth 5Y-5.23%
GM growth 3Y0.52%
GM growth 5Y-3.74%
FME.DE Yearly Profit, Operating, Gross MarginsFME.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. FME.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so FME is still creating some value.
  • The number of shares outstanding for FME has been reduced compared to 1 year ago.
  • FME has less shares outstanding than it did 5 years ago.
  • FME has a worse debt/assets ratio than last year.
FME.DE Yearly Shares OutstandingFME.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
FME.DE Yearly Total Debt VS Total AssetsFME.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • FME has an Altman-Z score of 1.83. This is not the best score and indicates that FME is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of FME (1.83) is comparable to the rest of the industry.
  • FME has a debt to FCF ratio of 6.19. This is a slightly negative value and a sign of low solvency as FME would need 6.19 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 6.19, FME is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
  • FME has a Debt/Equity ratio of 0.65. This is a neutral value indicating FME is somewhat dependend on debt financing.
  • FME has a Debt to Equity ratio of 0.65. This is in the better half of the industry: FME outperforms 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 6.19
Altman-Z 1.83
ROIC/WACC1.04
WACC5.09%
FME.DE Yearly LT Debt VS Equity VS FCFFME.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

2.3 Liquidity

  • A Current Ratio of 1.26 indicates that FME should not have too much problems paying its short term obligations.
  • FME has a better Current ratio (1.26) than 67.86% of its industry peers.
  • FME has a Quick Ratio of 1.26. This is a bad value and indicates that FME is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of FME (0.92) is better than 64.29% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.92
FME.DE Yearly Current Assets VS Current LiabilitesFME.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. FME.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 32.00% over the past year.
  • FME shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -1.51% yearly.
  • Looking at the last year, FME shows a small growth in Revenue. The Revenue has grown by 1.51% in the last year.
  • Measured over the past years, FME shows a small growth in Revenue. The Revenue has been growing by 1.91% on average per year.
EPS 1Y (TTM)32%
EPS 3Y11.44%
EPS 5Y-1.51%
EPS Q2Q%58.24%
Revenue 1Y (TTM)1.51%
Revenue growth 3Y0.39%
Revenue growth 5Y1.91%
Sales Q2Q%-0.29%

3.2 Future

  • Based on estimates for the next years, FME will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.03% on average per year.
  • Based on estimates for the next years, FME will show a small growth in Revenue. The Revenue will grow by 3.69% on average per year.
EPS Next Y-4.05%
EPS Next 2Y2.59%
EPS Next 3Y5.97%
EPS Next 5Y9.03%
Revenue Next Year-0.88%
Revenue Next 2Y1.45%
Revenue Next 3Y2.08%
Revenue Next 5Y3.69%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
FME.DE Yearly Revenue VS EstimatesFME.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B 25B
FME.DE Yearly EPS VS EstimatesFME.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. FME.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • FME is valuated reasonably with a Price/Earnings ratio of 9.08.
  • FME's Price/Earnings ratio is rather cheap when compared to the industry. FME is cheaper than 89.29% of the companies in the same industry.
  • FME's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.66.
  • FME is valuated reasonably with a Price/Forward Earnings ratio of 9.46.
  • 92.86% of the companies in the same industry are more expensive than FME, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 38.00. FME is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 9.08
Fwd PE 9.46
FME.DE Price Earnings VS Forward Price EarningsFME.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, FME is valued cheaply inside the industry as 82.14% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, FME is valued a bit cheaper than the industry average as 78.57% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.55
EV/EBITDA 6.09
FME.DE Per share dataFME.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.59%
EPS Next 3Y5.97%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. FME.DE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 3.83%, FME has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 1.84, FME pays a better dividend. On top of this FME pays more dividend than 96.43% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.81, FME pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.83%

5.2 History

  • The dividend of FME has a limited annual growth rate of 4.43%.
Dividend Growth(5Y)4.43%
Div Incr Years2
Div Non Decr Years3
FME.DE Yearly Dividends per shareFME.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • FME pays out 43.19% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • The dividend of FME is growing, but earnings are growing more, so the dividend growth is sustainable.
DP43.19%
EPS Next 2Y2.59%
EPS Next 3Y5.97%
FME.DE Yearly Income VS Free CF VS DividendFME.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
FME.DE Dividend Payout.FME.DE Dividend Payout, showing the Payout Ratio.FME.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

FME.DE Fundamentals: All Metrics, Ratios and Statistics

FRESENIUS MEDICAL CARE AG

FRA:FME (4/22/2026, 4:07:07 PM)

38.95

-0.65 (-1.64%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-24
Earnings (Next)05-05
Inst Owners44.85%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap11.43B
Revenue(TTM)19.63B
Net Income(TTM)978.37M
Analysts65.93
Price Target45.41 (16.59%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.83%
Yearly Dividend1.48
Dividend Growth(5Y)4.43%
DP43.19%
Div Incr Years2
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.86%
Min EPS beat(2)14.16%
Max EPS beat(2)35.55%
EPS beat(4)4
Avg EPS beat(4)22.94%
Min EPS beat(4)14.16%
Max EPS beat(4)35.55%
EPS beat(8)8
Avg EPS beat(8)21.57%
EPS beat(12)10
Avg EPS beat(12)16.05%
EPS beat(16)12
Avg EPS beat(16)12.94%
Revenue beat(2)1
Avg Revenue beat(2)0.93%
Min Revenue beat(2)-1.71%
Max Revenue beat(2)3.58%
Revenue beat(4)2
Avg Revenue beat(4)0.32%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)3.58%
Revenue beat(8)4
Avg Revenue beat(8)-0.14%
Revenue beat(12)5
Avg Revenue beat(12)-0.25%
Revenue beat(16)7
Avg Revenue beat(16)-0.28%
PT rev (1m)-0.82%
PT rev (3m)-4.5%
EPS NQ rev (1m)-0.52%
EPS NQ rev (3m)29.57%
EPS NY rev (1m)2.65%
EPS NY rev (3m)-0.74%
Revenue NQ rev (1m)-0.23%
Revenue NQ rev (3m)-5.93%
Revenue NY rev (1m)-1.61%
Revenue NY rev (3m)-3.66%
Valuation
Industry RankSector Rank
PE 9.08
Fwd PE 9.46
P/S 0.58
P/FCF 6.55
P/OCF 4.26
P/B 0.86
P/tB N/A
EV/EBITDA 6.09
EPS(TTM)4.29
EY11.01%
EPS(NY)4.12
Fwd EY10.57%
FCF(TTM)5.94
FCFY15.26%
OCF(TTM)9.14
OCFY23.46%
SpS66.89
BVpS45.36
TBVpS-5.17
PEG (NY)N/A
PEG (5Y)N/A
Graham Number66.1712 (69.89%)
Profitability
Industry RankSector Rank
ROA 3.16%
ROE 7.35%
ROCE 7.13%
ROIC 5.3%
ROICexc 5.78%
ROICexgc 16.63%
OM 9%
PM (TTM) 4.98%
GM 25.62%
FCFM 8.88%
ROA(3y)2.08%
ROA(5y)2.19%
ROE(3y)4.9%
ROE(5y)5.43%
ROIC(3y)4.02%
ROIC(5y)3.98%
ROICexc(3y)4.29%
ROICexc(5y)4.23%
ROICexgc(3y)11.55%
ROICexgc(5y)11.07%
ROCE(3y)5.42%
ROCE(5y)5.44%
ROICexgc growth 3Y23.76%
ROICexgc growth 5Y-0.49%
ROICexc growth 3Y19.48%
ROICexc growth 5Y-3.49%
OM growth 3Y10.69%
OM growth 5Y-6.44%
PM growth 3Y12.82%
PM growth 5Y-5.23%
GM growth 3Y0.52%
GM growth 5Y-3.74%
F-Score8
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 6.19
Debt/EBITDA 2.64
Cap/Depr 62.47%
Cap/Sales 4.78%
Interest Coverage 4.9
Cash Conversion 82.09%
Profit Quality 178.22%
Current Ratio 1.26
Quick Ratio 0.92
Altman-Z 1.83
F-Score8
WACC5.09%
ROIC/WACC1.04
Cap/Depr(3y)48.17%
Cap/Depr(5y)48.21%
Cap/Sales(3y)4.06%
Cap/Sales(5y)4.23%
Profit Quality(3y)290.62%
Profit Quality(5y)248.93%
High Growth Momentum
Growth
EPS 1Y (TTM)32%
EPS 3Y11.44%
EPS 5Y-1.51%
EPS Q2Q%58.24%
EPS Next Y-4.05%
EPS Next 2Y2.59%
EPS Next 3Y5.97%
EPS Next 5Y9.03%
Revenue 1Y (TTM)1.51%
Revenue growth 3Y0.39%
Revenue growth 5Y1.91%
Sales Q2Q%-0.29%
Revenue Next Year-0.88%
Revenue Next 2Y1.45%
Revenue Next 3Y2.08%
Revenue Next 5Y3.69%
EBIT growth 1Y39.46%
EBIT growth 3Y11.12%
EBIT growth 5Y-4.66%
EBIT Next Year70.62%
EBIT Next 3Y23.59%
EBIT Next 5Y15.26%
FCF growth 1Y4.8%
FCF growth 3Y7.67%
FCF growth 5Y-11.14%
OCF growth 1Y12.36%
OCF growth 3Y7.35%
OCF growth 5Y-8.73%

FRESENIUS MEDICAL CARE AG / FME.DE Fundamental Analysis FAQ

What is the fundamental rating for FME stock?

ChartMill assigns a fundamental rating of 5 / 10 to FME.DE.


What is the valuation status for FME stock?

ChartMill assigns a valuation rating of 6 / 10 to FRESENIUS MEDICAL CARE AG (FME.DE). This can be considered as Fairly Valued.


How profitable is FRESENIUS MEDICAL CARE AG (FME.DE) stock?

FRESENIUS MEDICAL CARE AG (FME.DE) has a profitability rating of 5 / 10.


Can you provide the financial health for FME stock?

The financial health rating of FRESENIUS MEDICAL CARE AG (FME.DE) is 5 / 10.


How sustainable is the dividend of FRESENIUS MEDICAL CARE AG (FME.DE) stock?

The dividend rating of FRESENIUS MEDICAL CARE AG (FME.DE) is 7 / 10 and the dividend payout ratio is 43.19%.